TB Treatment


1. Diagnosis Confirmation

  • Tests: Before starting treatment, TB is diagnosed through tests such as:
    • Sputum test (microscopy and culture)
    • Chest X-ray
    • Tuberculin skin test (TST) or Interferon-Gamma Release Assays (IGRAs)
    • Molecular tests like GeneXpert
  • This helps differentiate between active TB and latent TB infection (LTBI).

2. Types of TB Treatment

a) Treatment for Active TB

  • Active TB requires a combination of antibiotics for 6 months or longer. The standard regimen is:
    1. Intensive Phase (2 months):
      • Rifampicin (R)
      • Isoniazid (H)
      • Pyrazinamide (Z)
      • Ethambutol (E)
    2. Continuation Phase (4 months):
      • Rifampicin (R)
      • Isoniazid (H)

b) Treatment for Latent TB

  • For individuals with latent TB (no symptoms but a positive test), treatment may involve fewer drugs for a shorter duration:
    • Isoniazid for 6-9 months
    • Rifampin for 4 months
    • A combination of Isoniazid and Rifapentine once weekly for 3 months.

3. Drug-Resistant TB (MDR-TB and XDR-TB)

  • MDR-TB (Multi-Drug Resistant TB): Resistant to Rifampicin and Isoniazid. Treatment involves second-line drugs like:
    • Fluoroquinolones (e.g., levofloxacin, moxifloxacin)
    • Injectable agents (e.g., amikacin, kanamycin)
    • New drugs: Bedaquiline, Delamanid
  • Treatment duration: 18-24 months or longer.
  • XDR-TB (Extensively Drug-Resistant TB): Requires specialized regimens, often including new and repurposed drugs.

4. Supportive Care

  • Nutritional Support: A balanced diet to strengthen the immune system.
  • Regular Monitoring: Monthly checkups to monitor progress, side effects, and drug adherence.
  • Address Side Effects: Common side effects include nausea, liver toxicity, and visual disturbances.

5. Adherence to Treatment

  • DOTS (Directly Observed Treatment, Short-course):
    • Health workers supervise medication intake to ensure compliance.
    • Reduces the risk of drug resistance.

6. Preventive Measures

  • Vaccination: BCG vaccine is given in countries with high TB prevalence to prevent severe forms of TB in children.
  • Isolation: Active TB patients may need isolation during the initial phase of treatment to prevent spreading.
  • Screening of close contacts.

7. Consult Healthcare Professionals

TB treatment must be supervised by a medical professional to ensure the correct regimen and to manage complications or resistance. Self-medication or incomplete treatment can lead to drug resistance and treatment failure.

Published by Gemechu Abdissa

I am the best

Leave a comment

Design a site like this with WordPress.com
Get started